Redpoint Investment Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Redpoint Investment Management's MDT Position: Q3 2022 in Review
Redpoint Investment Management reduced its Medtronic (MDT) stake by 14% in Q3 2022, selling an estimated $420K and leaving 27,898 shares worth $2.25M. The position accounts for 0.33% of the portfolio, ranked #70.
Redpoint Investment Management first reported a position in MDT in Q4 2017 and has held it in 20 quarters since. The position peaked at $10.7M in Q4 2019. 1,930 funds tracked by Wall St. Rank hold MDT as of Q3 2022.
- Redpoint Investment Management held 27,898 shares of Medtronic worth $2.25M as of Q3 2022.
- Redpoint Investment Management sold 4,670 Medtronic shares in Q3 2022, an estimated $420K.
- Medtronic made up 0.33% of Redpoint Investment Management's portfolio in Q3 2022, its #70 holding.
- Redpoint Investment Management first reported a position in Medtronic in Q4 2017 and has held it in 20 quarters since.
- Redpoint Investment Management's Medtronic position peaked at $10.7M in Q4 2019.
- 1,930 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.
Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.